AG
Artal Group Portfolio holdings
AUM
$930M
This Quarter Return
+13.9%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$2.06B
AUM Growth
+$2.06B
(-5.4%)
Cap. Flow
+$28.8M
Cap. Flow
% of AUM
1.4%
Top 10 Holdings %
Top 10 Hldgs %
62.6%
Holding
111
New
10
Increased
20
Reduced
15
Closed
11
Top Buys
Top Sells
| 1 |
NVIDIA
NVDA
|
$38.3M |
| 2 |
Avantor
AVTR
|
$14.7M |
| 3 |
Huazhu Hotels Group
HTHT
|
$12.7M |
| 4 |
BPMC
Blueprint Medicines
BPMC
|
$11M |
| 5 |
CHNG
Change Healthcare Inc. Common Stock
CHNG
|
$11M |
Sector Composition
| 1 | Healthcare | 59.61% |
| 2 | Consumer Discretionary | 31.67% |
| 3 | Technology | 3.51% |
| 4 | Communication Services | 1.1% |
| 5 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Melco Resorts & Entertainment
MLCO
$3.88B
| – | – | 0 | – | – |
|
102
Morgan Stanley
MS
$240B
| – | – | 0 | – | – |
|
103
Neurocrine Biosciences
NBIX
$13.8B
| – | – | 0 | – | – |
|
104
Rocket Pharmaceuticals
RCKT
$354M
| – | – | -360,000 | Closed | -$5.4M |
|
105
Arcus Biosciences
RCUS
$1.13B
| – | – | -270,000 | Closed | -$2.15M |
|
106
SPDR S&P Biotech ETF
XBI
$5.07B
| – | – | 0 | – | – |
|
|
LGF.A
107
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| – | – | 0 | – | – |
|
|
NGM
108
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| – | – | -100,000 | Closed | -$1.46M |
|
|
CHNG
109
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| – | – | -750,000 | Closed | -$11M |
|
|
DLPH
110
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
| – | – | 0 | – | – |
|
|
ALDR
111
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| – | – | -850,000 | Closed | -$10M |
|